Detalhe da pesquisa
1.
The Role of Donor Lymphocyte Infusion (DLI) in Post-Hematopoietic Cell Transplant (HCT) Relapse for Chronic Myeloid Leukemia (CML) in the Tyrosine Kinase Inhibitor (TKI) Era.
Biol Blood Marrow Transplant
; 26(6): 1137-1143, 2020 06.
Artigo
Inglês
| MEDLINE | ID: mdl-32062061
2.
Maintenance Tyrosine Kinase Inhibitors Following Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelogenous Leukemia: A Center for International Blood and Marrow Transplant Research Study.
Biol Blood Marrow Transplant
; 26(3): 472-479, 2020 03.
Artigo
Inglês
| MEDLINE | ID: mdl-31669399
3.
Managing haematology and oncology patients during the COVID-19 pandemic: interim consensus guidance.
Med J Aust
; 212(10): 481-489, 2020 06.
Artigo
Inglês
| MEDLINE | ID: mdl-32401360
4.
Worldwide Network for Blood and Marrow Transplantation Recommendations for Establishing a Hematopoietic Cell Transplantation Program, Part I: Minimum Requirements and Beyond.
Biol Blood Marrow Transplant
; 25(12): 2322-2329, 2019 12.
Artigo
Inglês
| MEDLINE | ID: mdl-31071457
5.
The Concentration of Total Nucleated Cells in Harvested Bone Marrow for Transplantation Has Decreased over Time.
Biol Blood Marrow Transplant
; 25(7): 1325-1330, 2019 07.
Artigo
Inglês
| MEDLINE | ID: mdl-30716454
6.
Assessment of Impact of HLA Type on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia.
Biol Blood Marrow Transplant
; 24(3): 581-586, 2018 03.
Artigo
Inglês
| MEDLINE | ID: mdl-29032274
7.
Donor Experiences of Second Marrow or Peripheral Blood Stem Cell Collection Mirror the First, but CD34+ Yields Are Less.
Biol Blood Marrow Transplant
; 24(1): 175-184, 2018 01.
Artigo
Inglês
| MEDLINE | ID: mdl-28958894
8.
Combined beta-glucosylceramide and ambroxol hydrochloride in patients with Gaucher related Parkinson disease: From clinical observations to drug development.
Blood Cells Mol Dis
; 68: 117-120, 2018 02.
Artigo
Inglês
| MEDLINE | ID: mdl-27866808
9.
Design of a framework for the deployment of collaborative independent rare disease-centric registries: Gaucher disease registry model.
Blood Cells Mol Dis
; 68: 232-238, 2018 02.
Artigo
Inglês
| MEDLINE | ID: mdl-28190666
10.
Prognostic Limitations of Donor T Cell Chimerism after Myeloablative Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes.
Biol Blood Marrow Transplant
; 23(5): 840-844, 2017 May.
Artigo
Inglês
| MEDLINE | ID: mdl-28167152
11.
Graft Transit Time Has No Effect on Outcome of Unrelated Donor Hematopoietic Cell Transplants Performed in Australia and New Zealand: A Study from the Australasian Bone Marrow Transplant Recipient Registry.
Biol Blood Marrow Transplant
; 23(1): 147-152, 2017 01.
Artigo
Inglês
| MEDLINE | ID: mdl-27717872
12.
Long-term outcomes, secondary malignancies and stem cell collection following bendamustine in patients with previously treated non-Hodgkin lymphoma.
Br J Haematol
; 178(2): 250-256, 2017 07.
Artigo
Inglês
| MEDLINE | ID: mdl-28419413
13.
Exploring the patient journey to diagnosis of Gaucher disease from the perspective of 212 patients with Gaucher disease and 16 Gaucher expert physicians.
Mol Genet Metab
; 122(3): 122-129, 2017 11.
Artigo
Inglês
| MEDLINE | ID: mdl-28847676
14.
A no-prophylaxis platelet-transfusion strategy for hematologic cancers.
N Engl J Med
; 368(19): 1771-80, 2013 May 09.
Artigo
Inglês
| MEDLINE | ID: mdl-23656642
15.
Primary antifungal prophylaxis in adult patients with acute lymphoblastic leukaemia: a multicentre audit.
J Antimicrob Chemother
; 71(2): 497-505, 2016 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-26518050
16.
Enzyme replacement therapy with taliglucerase alfa: 36-month safety and efficacy results in adult patients with Gaucher disease previously treated with imiglucerase.
Am J Hematol
; 91(7): 661-5, 2016 07.
Artigo
Inglês
| MEDLINE | ID: mdl-27102949
17.
Comparison of outcomes of allogeneic transplantation for chronic myeloid leukemia with cyclophosphamide in combination with intravenous busulfan, oral busulfan, or total body irradiation.
Biol Blood Marrow Transplant
; 21(3): 552-8, 2015 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-25528388
18.
Autologous is superior to allogeneic hematopoietic cell transplantation for acute promyelocytic leukemia in second complete remission.
Biol Blood Marrow Transplant
; 20(7): 1021-5, 2014 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-24691221
19.
Reduced-intensity hematopoietic cell transplantation for patients with primary myelofibrosis: a cohort analysis from the center for international blood and marrow transplant research.
Biol Blood Marrow Transplant
; 20(1): 89-97, 2014 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-24161923
20.
Allotransplantation for patients age ≥40 years with non-Hodgkin lymphoma: encouraging progression-free survival.
Biol Blood Marrow Transplant
; 20(7): 960-8, 2014 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-24641829